NO304230B1 - Piperazinforbindelse, medikament og farmas°ytisk preparat omfattende denne - Google Patents

Piperazinforbindelse, medikament og farmas°ytisk preparat omfattende denne

Info

Publication number
NO304230B1
NO304230B1 NO950560A NO950560A NO304230B1 NO 304230 B1 NO304230 B1 NO 304230B1 NO 950560 A NO950560 A NO 950560A NO 950560 A NO950560 A NO 950560A NO 304230 B1 NO304230 B1 NO 304230B1
Authority
NO
Norway
Prior art keywords
drug
pharmaceutical composition
piperazine compound
piperazine
compound
Prior art date
Application number
NO950560A
Other languages
English (en)
Other versions
NO950560L (no
NO950560D0 (no
Inventor
Philippe Manoury
Daniel Obitz
Michel Peynot
Mireille Sevrin
Pascal George
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO950560D0 publication Critical patent/NO950560D0/no
Publication of NO950560L publication Critical patent/NO950560L/no
Publication of NO304230B1 publication Critical patent/NO304230B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO950560A 1994-02-16 1995-02-15 Piperazinforbindelse, medikament og farmas°ytisk preparat omfattende denne NO304230B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9401736A FR2716193B1 (fr) 1994-02-16 1994-02-16 Dérivés de 1[2-(1h-inden-3-yl)ethyl]-4-(naphtalen-1-yl)piperazine, leur préparation et leur application en thérapeutique.

Publications (3)

Publication Number Publication Date
NO950560D0 NO950560D0 (no) 1995-02-15
NO950560L NO950560L (no) 1995-08-17
NO304230B1 true NO304230B1 (no) 1998-11-16

Family

ID=9460124

Family Applications (1)

Application Number Title Priority Date Filing Date
NO950560A NO304230B1 (no) 1994-02-16 1995-02-15 Piperazinforbindelse, medikament og farmas°ytisk preparat omfattende denne

Country Status (18)

Country Link
US (1) US5530002A (no)
EP (1) EP0668273A1 (no)
JP (1) JPH07252243A (no)
KR (1) KR950032160A (no)
CN (1) CN1112554A (no)
AU (1) AU680327B2 (no)
CA (1) CA2142535A1 (no)
CZ (1) CZ39395A3 (no)
FI (1) FI950670A (no)
FR (1) FR2716193B1 (no)
HU (1) HUT71898A (no)
IL (1) IL112661A0 (no)
NO (1) NO304230B1 (no)
NZ (1) NZ270500A (no)
PL (1) PL307286A1 (no)
RU (1) RU95102147A (no)
SK (1) SK20795A3 (no)
ZA (1) ZA951235B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737724B1 (fr) * 1995-08-09 1997-09-05 Synthelabo Derives de 1-[2-(2,3-dihydro-1h-inden-1-yl)ethyl]-4- (naphtalen-1-yl) piperazine, leur preparation et leur application en therapeutique
FR2737723B1 (fr) * 1995-08-09 1997-09-05 Synthelabo Derives de 1-(2-(1h-inden-3-yl)ethyl)-4-(naphtalen-1-yl)- piperazine, leur preparation et leur application en therapeutique
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
DE602005019098D1 (de) * 2004-12-21 2010-03-11 Hoffmann La Roche Tetralin- und indanderivate und deren anwendungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130646A (en) * 1975-07-25 1978-12-19 E. R. Squibb & Sons, Inc. 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof
US4845221A (en) * 1988-04-15 1989-07-04 American Home Products Corporation Serotonergic substituted piperazinyl tetralins
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
IT1255178B (it) * 1992-06-26 1995-10-20 Pierrel Spa N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica

Also Published As

Publication number Publication date
CA2142535A1 (en) 1995-08-17
HUT71898A (en) 1996-02-28
RU95102147A (ru) 1996-12-10
AU1224495A (en) 1995-08-24
NZ270500A (en) 1996-02-27
FI950670A (fi) 1995-08-17
CZ39395A3 (en) 1995-10-18
PL307286A1 (en) 1995-08-21
NO950560L (no) 1995-08-17
US5530002A (en) 1996-06-25
FR2716193A1 (fr) 1995-08-18
SK20795A3 (en) 1995-09-13
JPH07252243A (ja) 1995-10-03
AU680327B2 (en) 1997-07-24
CN1112554A (zh) 1995-11-29
KR950032160A (ko) 1995-12-20
EP0668273A1 (fr) 1995-08-23
FI950670A0 (fi) 1995-02-15
NO950560D0 (no) 1995-02-15
IL112661A0 (en) 1995-05-26
HU9500453D0 (en) 1995-03-28
ZA951235B (en) 1996-01-18
FR2716193B1 (fr) 1996-04-05

Similar Documents

Publication Publication Date Title
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
NO20010078D0 (no) Fenoksyeddiksyrederivat og farmasöytisk sammensetning omfattende det samme
NO306401B1 (no) Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
ATE187063T1 (de) Arzneimittel
NO962694D0 (no) Percutant farmasöytisk preparat
DK0920302T4 (da) Farmaceutisk aerosolsammensætning
NO943888D0 (no) Farmasöytisk preparat
NO306257B1 (no) 11-(substituert fenyl)-östra-4,9-dien-derivater, farmasöytisk preparat og anvendelse derav
NO985368D0 (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
FI955311A0 (fi) Farmaseuttinen koostumuspohja
NO308533B1 (no) Heteroarylaminer, anvendelse derav og farmasøytisk preparat
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon
ID29294A (id) Komposisi farmasi
BR9507768A (pt) Composição farmacêutica
ID25857A (id) Komposisi farmasi
ID18698A (id) Komposisi farmasi
NO20012943D0 (no) Nye heterocykliske forbindelser og farmasöytiske sammensetninger inneholdende det samme
EE200100281A (et) Analgeetiline ravimkoostis
NO304230B1 (no) Piperazinforbindelse, medikament og farmas°ytisk preparat omfattende denne
NO308213B1 (no) Substituerte indanylidinacetylguanidiner, deres anvendelse og medikamenter inneholdende forbindelsene
FI951155A (fi) Farmaseuttinen valmiste